Natural products (NPs) have always played key roles in drug discovery. Scientific experts now are expanding the capabilities of natural chemistry through combinatorial biosynthesis, for example different biosynthetic enzymes are modified to alter functional groups, regiochemistry and scaffold, etc. Diversity-oriented synthesis (DOS) is widely used to build both quantitative and qualitative libraries of natural product. Emerging synthetic biology technologies can further accelerate the refinement of combinatorial biosynthesis as a incredible platform to diversify natural chemical drug leads. MCB technology has therefore been developed to greatly expand the diversity and application of natural molecules. In addition, with the deep understanding of the biosynthetic mechanism, the application of this technology has huge potential in building libraries of polyketide, polypeptide and polyketide-polypeptide hybrid natural products.
BOC Sciences has offered new solutions for the combinatorial biosynthesis of natural products using MCB approaches, which can accelerate novel drug discovery by combining synthetic biology with synthetic chemistry.
Figure 1. Multiplex combinatorial biosynthesis process. (Yan, Y.; et al. 2013)
BOC Sciences combines MCB techniques and DOS strategies to apply the concepts of combinatorial chemistry to all stages of biosynthesis:
BOC Sciences provides professional, rapid and high-quality services of Multiplex Combinatorial Biosynthesis (MCB) at competitive prices for global customers. Personalized and customized services of Multiplex Combinatorial Biosynthesis (MCB) can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.